olaratumab
ravulizumab
presentation
brolucizumab
talizumab
immunocytology
intetumumab
antinucleosome
polyvalent
idiospecific
autoantibody
antisynthetase
tucotuzumab
radioimmunodiagnosis
immunostrip
radioimmunochemistry
serospecific
soravtansine
elotuzumab
sonepcizumab
specific
immunosorbance
immunobinding
-les-
miniantibody
radioimmunoelectrophoresis
bococizumab
complement
sasanlimab
toripalimab
pozelimab
zenocutuzumab
dinutuximab
retifanlimab
solitomab
affibody
lorvotuzumab
immunomolecule
vanucizumab
ziltivekimab
sintilimab
radioimmunoreactivity
active immunity
autoagglutinin
radioimmunoprecipitate
antimonoclonal
glembatumumab
autocentromere